Thread by @hmkyale

Hey #ACC22 presenters, especially late breaking studies of consequence. If you don't have simultaneous peer-reviewed pub, consider #preprint what you presented so it's archived & accessible. Let’s make it normative. @medrxivpreprint @yaleHFdoc #LBCT @EricTopol @CMichaelGibson

@medrxivpreprint @yaleHFdoc @EricTopol @CMichaelGibson For all #ACC22 presenters, preprinting is easy; we accept scientific studies, screen rapidly, post quickly. Non-profit. It is of the community-available throughout the world, understood as pre-peer reviewed, and citable. Almost all reputable journals are fine with it, incl @NEJM.

@medrxivpreprint @yaleHFdoc @EricTopol @CMichaelGibson @NEJM In the pandemic @medrxivpreprint stimulated discussions about research in progress, & many examples of advancing research. Cardiology has not yet fully embraced it, yet is this work any less important? All fields should accelerate public scientific communication & #openscience.

@medrxivpreprint @yaleHFdoc @EricTopol @CMichaelGibson @NEJM Presentations at meetings can be ephemeral. Hard to find. Difficult to remember. #preprints are enduring artifacts that anchor where science was at the time. They foster connections & communications. I urge our cardiology community to embrace new norms. #ACC22 @medrxivpreprint

@medrxivpreprint @yaleHFdoc @EricTopol @CMichaelGibson @NEJM And as disclosure…I am a co-founder @medrxivpreprint and active in it, but receive no renumeration and have no equity. It is non-profit and of the community. No firewall. I push because I think it is a better way and advances science in new ways. #ACC22 @jsross119 @YaleMed

@medrxivpreprint @yaleHFdoc @EricTopol @CMichaelGibson @NEJM @jsross119 @YaleMed At @medrxivpreprint we have done our best to de-risk preprints for clinical medicine. We require registration for trials, screen for potential problems, coordinate with journals, & advocate for authors to have their work accessible and available as evidence of their work. #ACC22